NONI IN NEURODEGENERATIVE DISEASES Parkinson’s Disease Alzheimer’s disease Senile Dementia ...

34
NONI NONI IN IN NEURODEGENERATIVE NEURODEGENERATIVE DISEASES DISEASES Parkinson’s Disease Parkinson’s Disease Alzheimer’s disease Alzheimer’s disease Senile Dementia Senile Dementia Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis (ALS) (ALS)
  • date post

    18-Dec-2015
  • Category

    Documents

  • view

    223
  • download

    1

Transcript of NONI IN NEURODEGENERATIVE DISEASES Parkinson’s Disease Alzheimer’s disease Senile Dementia ...

Page 1: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

NONINONIININ

NEURODEGENERATIVE NEURODEGENERATIVE DISEASESDISEASES

Parkinson’s DiseaseParkinson’s DiseaseAlzheimer’s diseaseAlzheimer’s diseaseSenile DementiaSenile DementiaAmyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)

Page 2: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

FREE RADICALS AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES:

RELEVANCE OF INDIAN NONI, A POWERFUL ANTIOXIDANTS AND NATURAL NUTRITIONAL SUPPLEMENTS

ABSTRACT

Oxidants and antioxidants plays an important role in maintaining a balance

between free radicals and the antioxidant system of the body. Free radicals are

created either by the normal metabolism process or derived from environmental

sources. A complex natural endogenous antioxidant system exists in our body

which is responsible for prevention of damage by pro oxidants or free radicals.

Impaired endogenous antioxidant system favors accumulation of free radicals,

which not only induces the process of lipid peroxidation but also plays a central

role in neurodegeneration. Neurodegenerative disorders remains always an

important source of morbidity and suffering for the human society. The free-

radical-mediated oxidative injury to the nervous system like strokeor

traumaand various chronic neurodegenerative disorders are

being recognized.

Page 3: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

The increased incidence of neurodegenerative diseases like parkinson’s diseases,

Alzheimer’s disease, lateral sclerosis, senile dementia etc may be attributed to a

pro-oxidative environment caused by smoking, alcohol abuse, ultra-violet ray

radiations, air pollution, pressure packed life style as well as inappropriate

nutrition. The dependence of disease severity by an imbalance between oxidants

and natural defenses suggests that oxidative stress plays a pivotal role in the

progression of neurodegenerative diseases and could serve as a useful target for

treatment. A high antioxidant food supplement can prevent or reduce the

degenerative changes in brain and spinal cord by enhancing or modifying the

body’s endogenous antioxidant system and also by providing exogenous

antioxidants to the body. Indian Noni contains all the antioxidant vitamins,

important trace minerals and rich with phytochemicals. The synergistic actions of

all those ingredients just make Indian Noni a very powerful antioxidant food

supplement that may help in prevention and/or therapeutic intention in various

neurodegenerative diseases. It is our attempt through this clinical trial to put forth

the evidence for involvement of free radicals in pathophysiology of

neurodegenerative diseases and the action of Indian Noni in or therapeutic

purposes of various neurodegenerative diseases.

Page 4: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

ROLE OF INDIAN NONI IN CHRONIC NEURODEGENARATIVE

DISEASES NEURODEGENERATIVE DISEASES: AN OVERVIEW

Neurodegenerative disease is a condition which affects brain function. It result from deterioration of neurons. It is a heterogeneous group of diseases of the nervous system, including the brain, spinal cord, and peripheral nerves that have many different etiology. Many are hereditary, some are secondary to toxic or metabolic processes, and others result from infections. The free-radical-mediated oxidative injury to neurons is one of the major cause of various neurodegenerative diseases. Due to the prevalence, morbidity, and mortality of the neurodegenerative diseases, they represent significant medical, social, and financial burden on the society. Neuropathologically, these are characterised by abnormalities of relatively specific regions of the brain and specific populations of neurons. The degenerating neuron clusters in the different diseases determine the clinical phenotype of that particular illness. Recent investigations in medical genetics have

identified specific genes for various neurodegenerative disorders

Page 5: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

SOME COMMON NEURO DEGENERATIVE DISEASES

Parkinson’s Disease

Alzheimer’s disease

Frontotemporal Dementia

Amyotrophic Lateral Sclerosis (ALS)

Page 6: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

PARKINSON’S DISEASE

Parkinson's disease may arise as a combined consequence of the ongoing

aging process coupled with free radical’s damaging effects that accelerate

the process of substantial nigral’s cells death in brain

Neuropathological changes :

The major neuropathologic findings in PD are loss of pigmented

dopaminergic neurons in the substantia nigra and the presence of Lewy

bodies.

Page 7: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)
Page 8: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

ALZHEIMER’S DISEASE

Alzheimer's disease is the most common form of dementia among older

people. It involves the parts of the brain that control thought, memory, and

language. Some of the deterioration may be related to the loss of

neurotransmitters –the acetylcholine.

Neuropathological changes :

Generalised cortical atrophy with shrinkage of the amygdala and

hippocampus. Selective dysfunction and death of neocortex, hippocampus,

amygdala, basal forebrain, and brainstem.The deposition of an abnormal

protein outside nerve cells in the form of amyloid. These are called diffuse

plaques. Amyloid also accumulates in the walls of small blood vessels in

the brain. This is amyloid angiopathy. Levels of the neurotransmitter

acetylcholine are reduced. Levels of the neurotransmitters serotonin,

norepinephrine, and somatostatin are also often reduced.

Page 9: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)
Page 10: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

SENILE DEMENTIA Senile Dementia is the progressive decline in cognitive function due to

damage or disease in the brain beyond what might be expected from

normal aging. The affected areas may be memory, attention, language and

problem solving, although particularly in the later stages of the condition,

affected persons may be disoriented in time (not knowing what day, week,

month or year it is), disoriented in place (not knowing where they are) and

disoriented in person (not knowing who they are).

Most common causes are

• Alzheimer's disease

• Vascular dementia (also known as multi-infarct dementia)

• Dementia with Lewy bodies

• Frontotemporal lobar degeneration (FTLD), including Pick's diseases

Page 11: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Amyotrophic lateral sclerosis is a chronic, progressive, almost invariably

fatal neurological disease. It is marked by gradual degeneration of the

neurons in the central nervous system that control voluntary muscles

movement. The disorder causes muscles weakness and atrophy throughout

the body. In ALS, both the upper motor neurons and the lower motor

neurons degenerate or die, ceasing to send messages to muscles. Unable to

function, the muscles gradually weaken, waste away i.e atrophied, and have

fasciculations because of denervation

Page 12: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)
Page 13: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

THE FREE RADICALSFree radicals are highly reactive molecules having unpaired electrons in its outer

sphere. Generation of free radicals or highly Reactive Oxygen Species (ROS) is an

integral feature of normal cellular function like mitochondrial respiratory chain,

phagocytosis, arachidonic acid metabolism, ovulation, and fertilisation. Their

production however, multiplies several folds during pathological conditions.

Types of free radicals or reactive oxygen species (ROS) include the hydroxyl radical

(OH.), the superoxide radical (O.2), the nitric oxide radical (NO.) and the lipid peroxyl

radical (LOO.). Most of the superoxide radicals are formed in the mitochondrial and

microsomal electron transport chain. The hydroxyl free radicals are very reactive

species and rapidly attack the macromolecules in cells. The superoxide radical, lipid

hydroperoxides, and nitric oxide are comparatively less reactive. A limited number of

enzymes like xanthine-oxidase, tryptophan dioxygenase, and indole-amine dioxygenase

produce the superoxide free radical directly. Further, nitric oxide free radical (NO) can

react with superoxide radical to form a highly toxic peroxynitrite (ONOO). When

peroxynitrite reacts with human body fluids and tissues, nitrotyrosines are

generated, which have been detected in human brain and may be

increased in neurodegenerative diseases.

Page 14: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

Free radicals or Reactive oxygen species (ROS) causes several damaging

effects by attacking the lipids, proteins, enzymes, carbohydrates, and DNA

of cells and tissues. They induce undesirable oxidation, causes membrane

damage, protein modification, DNA damage, and cell death induced by

DNA fragmentation and lipid peroxidation. This oxidative damage

associated with free radicals is believed to be involved in the

pathophysiological role in aging of skin and also in several diseases like

heart disease (atherosclerosis), cataract, cancer, diabetic retinopathy,

chronic inflammatory diseases of the gastrointestinal tract, organ

dysfunction, disseminated intravascular coagulation, chronic

neurodegenerative diseases like parkinson’s diseases, multiple sclerosis,

amyotrophic lateral sclerosis, spastic paraplegia, alzheimer’s diseases etc.

Antioxidants are believed to slow down the formation of free radicals,

protects the body by repairing the damage of cells and tissues.

Page 15: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)
Page 16: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)
Page 17: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

ANTIOXIDANT PROPERTY OF NONI The Endogenous antioxidants system and Role of Noni:

Our body has evolved with endogenous defense mechanisms to protect

against free radical induced cell damage. Glutathione peroxidase, catalase,

and Superoxide dismutases are three primary antioxidant enzymes in our

body , which involved in direct elimination of free radicals or reactive

oxygen species from our body. They require micronutrient such as selenium,

iron, copper, zinc, and manganese as cofactors for their formation and

optimum catalytic and effective antioxidant activity. Noni contain all the

trace minerals that help for optimum catalytic activity of those three

important antioxidant enzymes for an effective antioxidant defense

mechanism.

Page 18: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

Glutathione, ascorbic acid, alpha-tocopherol, beta-carotene, bilirubin,

selenium, melatonin, uric acid etc., as a whole play a homoeostatic or

protective role against ROS produced during normal cellular metabolism

and after active oxidation insult. Noni contains many of the above phyto

chemicals and vitamins in abundant quantity. Glutathione (GSH) is the

most significant component which directly quenches Reactive Oxygen

Species (ROS) such as lipid peroxides and plays major role in xenobiotic

metabolism. Glutathione is a tripeptide made up of the amino acids

gamma-glutamic acid, cysteine, and glycine. Noni contain all those

glutathione making amino acids in abundant number. Thus Noni

increases the body’s glutathione level. Noni stimulates more melatonin

secretion from the pineal body. It also maintains ascorbate (vitamin

C) and alpha-tocopherol (vitamin E), in their reduced form, which also

exert an antioxidant effect by quenching free radicals.

Page 19: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)
Page 20: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

The Exogenous antioxidants: Contribution from Noni:

A number of other dietary antioxidants known as phytonutrients or phytochemicals that are being increasingly appreciated for their antioxidant activity. One example is flavonoids which are a group of polyphenolic compounds. They are responsible for the different brilliant colors such as blue, scarlet, and orange. Noni contain 150 above phytochemicals including all flavonoids. Flavonoids exhibit several biological effects such as antitumoural, anti-ischaemic, anti-allergic, anti-hepatotoxic, anti-ulcerative, and anti inflammatory activities. These are also known to inhibit the activities of several bad enzymes like lipoxygenase, cyclooxygenase, monooxygenase, xanthine oxidase, glutathione-S transferase, mitochondrial succino-oxidase, and protein kinases. Many of the biological activities of flavonoids are attributed to their antioxidant properties and free radical scavenging capabilities. Noni is rich with many flavonoids. Due to the inefficiency of our endogenous defense systems as well as highly exposure to environmental factors such as ,cigarette smoke, air pollutants, UV radiation, and also the existence of some physiopathological situations like inflammation, ischaemia/reperfusion, the ROS are produced in excess, and therefore increasing amounts of antioxidants present in Noni will be needed for diminishing the cumulative effect

of oxidative damage over an individual’s life span.

Page 21: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)
Page 22: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

OXIDATIVE STRESS IN THE NERVOUS SYSTEM

The oxidative stress is a shift towards the pro-oxidant (free radicals) in the

pro-oxidant/antioxidant balance system that can occur as a result of an

increase in oxidative metabolism. Its increase at the cellular level can come

as a consequence of several factors, including exposure to alcohol, cold,

medications, trauma, infections, toxins, radiation, strenuous physical

activity, and poor diet. Defense against all of these processes is

dependent upon the adequacy of various antioxidants that are found

abundantly in Noni. The nervous system – including the brain, spinal

cord, and peripheral nerves – is rich in both unsaturated fatty acids and

iron. The high lipid content of nervous tissue, coupled with its high aerobic

metabolic activity, makes it particularly susceptible to oxidative damage.

Page 23: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

There are several reasons why the brain and the nerves are especially

vulnerable to oxidative stress.

Relative to its size, the brain experiences an increased rate of oxidative activity, which creates a significant number of free radicals.

The normal activity which various chemicals create to establish nerve conduction is a major producer of free radicals. The brain and nerve tissue contain relatively low level of antioxidants.

In addition, those brain regions that are rich in catecholamines are exceptionally vulnerable to free radical generation. The catecholamine adrenaline, noradrenalin, and dopamine can spontaneously break down (auto-oxidise) to free radicals, or can be metabolized to radicals by the endogenous enzymes such as MAO (monoamine oxidases). One such region of the brain is the substantia nigra (SN), where a connection has been established between antioxidant depletion (including GSH)

and tissue degeneration.

Page 24: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

A number of in vitro studies have shown that antioxidants – both endogenous

and dietary supplements (Noni) – can protect nervous tissue from damage by

oxidative stress. Vitamin E was found to prevent cell death (apoptosis) in rat

neurons subjected to hypoxia followed by oxygen reperfusion. In the same

study it was shown that vitamin E prevented neuronal damage from reactive

nitrogen species. Both vitamin E and beta carotene were found to protect rat

neurons against oxidative stress from exposure to ethanol.

In an experimental model of diabetes-caused neurovascular dysfunction,

beta-carotene was found to protect cells most effectively, followed by

vitamin E and vitamin C. Most in vivo and clinical studies of the effects of

lipid soluble antioxidant supplementation on neurological diseases have

focused on vitamin E. A report in 1991 demonstrated that the rate at which

Parkinson’s disease progressed to the point when the patient required

treatment with levodopa was slowed by 2.5 years in patients given large

doses of vitamin C and vitamin E and other essential antioxidants .

Page 25: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

In a study, it was found that the risk for Parkinson’s

disease was lower for subjects who had higher dietary

intakes of antioxidants. In another study, it was found that

patients suffering from Parkinson’s disease had consumed

less of the antioxidants, beta-carotene and vitamin C than

did non-sufferers of the disease, implying that dietary

antioxidants found in Noni do play a protective role in this

disease.

Page 26: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

• There is substantial evidence that oxidative stress is a causative or at least

ancillary factor in the pathogenesis of major neurodegenerative diseases,

including Parkinson’s disease, Alzheimer’s disease, and amyotrophic

lateral sclerosis (ALS) as well as in cases of stroke, trauma, and seizures.

• Decreased levels of antioxidant enzyme activity have been reported in

patients with Parkinson’s disease. Evidence of increase in lipid

peroxidation and oxidation of DNA and proteins has indeed been seen in

the substantia nigra of patients affected with Parkinson’s disease.

• Similar increases in markers of oxidative stress have also been seen in

Alzheimer’s disease, and in both familial ALS (FALS) and sporadic ALS

(SALS) patients.

Page 27: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

Schizophrenia (SCZ) is also believed to have a component of free-radical

overload. Lipid peroxides have been found elevated in their blood and

increased pentane gas, a marker for lipid peroxidation, in the breath of

schizophrenics as compared with normal volunteers and with patients

having other psychiatric illness. The enzyme SOD was found increased,

possibly as an adaptive response to free radical overload in the patients of

SCZ. Studies of antioxidant treatment in schizophrenia have been very

few. Glutathione peroxidase level are also found reduced in SCZ patients.

Therefore a powerful antioxidants like Noni plays a vital role in

schizophrenia patients.

Page 28: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

CONCLUSION

Neurodegenerative disorders remain an important source of morbidity and

suffering for the humankind. The role of free-radical-mediated oxidative injury

in acute insults to the nervous system including stroke or trauma, as well as in

chronic neurodegenerative disorders, is being just recognized. As we know,

oxygen is an essential molecule for survival of majority of living organisms.

Oxidative stress is the harmful condition that occurs when there is an excess of

free radicals and/or a decrease in antioxidant levels. There is evidence to

suggest that increase in energy metabolism by aerobic pathways enhances the

intracellular concentration of free oxygen radicals, which in turn enhance the

rate of the autocatalytic process of lipid peroxidation, inducing damage to brain

structures, especially when physiological defenses become insufficient or

depleted. Antioxidants found in Noni combat oxidative stress by

neutralising the excess free radicals.

Page 29: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

The evidence to date for oxidative stress in PD, ALS, SCZ, AD and other

neurodegenerative diseases is strongly persuasive. Clinical studies show that a

number of events associated with Alzheimer’s diseases are capable of

stimulating production of free radicals and depletion of antioxidant levels.

Patients with Parkinson’s diseases also have reduced glutathione levels and

free radical damage is found in the form of increased lipid peroxidation and

oxidation of DNA bases. Tackling of the free radical involvement offers a

novel therapeutic target in such diseases.

Page 30: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

In the above Neuro Degenerative diseases when oxidative stress is

eventually proven to be primary or secondary in the aetiologic progression,

the therapeutic rewards of powerful antioxidants like Noni are likely to be

substantial. The essential consideration is to provide a powerful

antioxidants like Noni in those neurodegenerative diseases within the time

frame of or prior to maximal tissue damage. Clearly, strategies should aim

at limiting the free radicals production and oxidative stress, that may slow

the progression of neurodegenerative diseases. Patients can replete their

cellular and body stores antioxidants with the body’s most important

antioxidants, glutathione and other antioxidants through Noni to maintain

the antioxidant defense system that will help to prevent or delay the

progression of free radical related damages.

Page 31: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

Noni contains all the antioxidant vitamins such as Vitamin C, vitamin

E, beta-carotene, and all antioxidant trace minerals, glutathione and

lots of phytochemicals that may helps in preventive and therapeutic

role in various chronic neurodegenerative diseases. Preclinical

experimental studies have proven that Noni can reduce acute

neurological disorders by preventing lipid peroxidation and

diminishing free radical generation. In fact, they appear to be highly

beneficial in experimental models.

Page 32: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

CASES UNDER CLINICAL TRIAL

Name: Sudhir Chandra Pradhan. Age & sex: 78 Male

Address: Plot No 43,Laxmi Bihar, Sainik School, Bhubaneswar - 751005

Date: 10th July 2006

Diagnosis:

1. Alzheimer's diseases

2. Seizure

3. Metabolic encephalopathy

Page 33: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)

CLINICAL SIGNS AND SYMPTOMS

BEFORE USING NONI AFTER USING NONI- 78 DAYS

Drowsiness No drowsiness

Unable to sit or walk (No paralytic conditions)

Sitting on bed without any support. Standing and walking with little support

Memory impaired. Trying to recognize his family members.

Not responsive to any question asking

Response to all question but speech is not clear

B.P – 150/100 mm of Hg BP – 130/90 mm of Hg

Serum Na – 118 mmol/l (30th June 2006)

Serum Na – 126 mmol/I (Dt 18th September 2006)

Disturbed sleep Sound sleep

Hb % - 11g/dl

Palm and plantar reflection – normal

Palm and plantar reflection – normal

CT Scan of head – Cerebral Atrophic condition

CT Scan has not been done afterwards

Page 34: NONI IN NEURODEGENERATIVE DISEASES  Parkinson’s Disease  Alzheimer’s disease  Senile Dementia  Amyotrophic Lateral Sclerosis (ALS)